Home Podcasts Medlines

Medlines

Human Content, Inc. 3 Episodes Aug 21, 2026

Medlines is a weekly podcast that delivers the most important healthcare headlines to medical professionals. Hosted by Dr. Will Flanary (Dr. Glaucomflecken), Dr. Alok Patel, Adam Rose, and Eva Johnson, it covers clinical care, health policy, groundbreaking publications, and medical pop culture. The show offers clear, unbiased, fact-first reporting, helping listeners stay informed without the usual doom-scrolling. Produced by Human Content, Inc., it aims to keep healthcare professionals up to date in a fast-paced industry.

Episodes

Milestone Prescription Price Drops and the CTE Diagnostic Puzzle Aug 21, 2026 808 Friday, August 21, 2026 In today's episode, Dr. Will Flanary (@drglaucomflecken) & Eva Johnson cover a historic drop in prescription drug prices. Prices fell 3.1% over the past year, the steepest annual decline since 1963, and the anchors unpack what is actually driving it from generics to GLP-1 competition to the Inflation Reduction Act. They also break down why the national index does not alway

FDA Approves mRNA Flu Shot and AI Learns to Build Viruses Aug 14, 2026 779 Friday, August 14, 2026 In today's episode, Adam Rose (@adjoro) & Dr. Alok Patel (@alokpatelmd) cover the FDA's landmark approval of Moderna's first mRNA flu vaccine for adults. They break down the phase-three trial showing the mRNA shot produced fewer confirmed influenza cases than standard vaccines, and what a complicated insurance landscape means for access this flu season. Plus: researchers a

Our Blood Donation Crisis & An Organ Transplant First Aug 7, 2026 826 August 7, 2026 In today's episode, Dr. Will Flanary (@DrGlaucomflecken) & Eva Johnson cover the American Red Cross declaring its second-ever national blood crisis, with Type O blood critically low and hospitals postponing transfusions. They break down what's driving the shortage and debate whether blood donors deserve HOV-lane perks. Then: a 36-year-old Iowa woman with cystic fibrosis becomes the

The ChatGPT Medical Lawsuit & Why Statin Rules Just Changed Jul 31, 2026 849 Friday, July 31, 2026 In today's episode, Dr. Alok Patel (@alokpatelmd) & Adam Rose (@adjoro) cover a Florida man's lawsuit against OpenAI after ChatGPT repeatedly dismissed his pulmonary embolism symptoms as "not something dangerous." The case raises urgent questions about AI medical liability just as a new JAMA analysis reveals updated cholesterol guidelines now make 87.5 million US adults elig

Kalshi Prediction Market and CMS's 2027 Fee Schedule Overhaul Jul 24, 2026 766 Friday, July 24, 2026 In today's episode, Dr. Alok Patel (@alokpatelmd) & Eva Johnson cover CMS's sweeping 2027 physician fee schedule proposal, which would accelerate Medicare's shift from fee-for-service toward value-based, preventive care. They also unpack Kalshi's launch of clinical trial prediction markets; betting on FDA approvals is now a real thing, and the ethical questions are piling up

Aspirin vs. Blood Thinners, a 9-Year Endo Wait Ends & Cyclospora Hits Taco Bell Jul 17, 2026 661 Friday, July 17, 2026 In today’s episode, Dr. Will Flanary / Dr. Glaucomflecken (@drglaucomflecken) and Adam Rose cover the EPCAT III trial, which found that aspirin alone was non-inferior to an initial course of rivaroxaban followed by aspirin for preventing major blood clots after elective hip or knee replacement in predominantly standard-risk patients. They examine NICE’s draft recommendation

Medicare's $50 GLP-1 Program, an Altered Drug Trial & Cyclospora's 18-State Spread Jul 10, 2026 701 Friday, July 10, 2026 In today's episode, Dr. Will Flanary / Dr. Glaucomflecken (@drglaucomflecken) & Eva Johnson cover the retraction of the Advocate trial after FDA reviewers found the avacopan (Tavneos) dataset was unblinded, re-adjudicated, and altered before being relocked, throwing its approval for ANCA-associated vasculitis into doubt. They break down Medicare's new GLP-1 Bridge program,

ACA Enrollment Collapse, India's Chemo Crisis, & Amy Adams' Canceled CBS Show Jul 3, 2026 754 Friday, July 3, 2026 In today's inaugural episode, Dr. Will Flanary / Dr. Glaucomflecken (@drglaucomflecken) & Dr. Alok Patel (@alokpatelmd) cover a sharp drop in ACA marketplace enrollment after enhanced tax credits expired, from 24.2 million enrollees in 2025 to roughly 19.2 million in 2026 (a loss of 5 million Americans' health coverage). India is rationing two cornerstone chemotherapy drugs,

Healthcare News, Finally Fast Enough Jul 3, 2026 149 Struggling to stay on top of healthcare news because, well, you're too busy working in it? If only there were a way to catch up on things in less time than it takes to get prior auth approved. (Spoiler: There is.) Kick off your Fridays with Dr. Will Flanary (aka Dr. Glaucomflecken), Dr. Alok Patel, Adam Rose, and Eva Johnson as they bring you the week’s most important headlines across clinical ca

Medlines

Episodes

Recommended